178 related articles for article (PubMed ID: 23917391)
1. Association of biomarkers of inflammation, cartilage and bone turnover with gender, disease activity, radiological damage and sacroiliitis by magnetic resonance imaging in patients with early spondyloarthritis.
Almodóvar R; Ríos V; Ocaña S; Gobbo M; Casas ML; Zarco-Montejo P; Juanola X
Clin Rheumatol; 2014 Feb; 33(2):237-41. PubMed ID: 23917391
[TBL] [Abstract][Full Text] [Related]
2. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
[TBL] [Abstract][Full Text] [Related]
3. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
Kang KY; Jung JY; Hong YS; Ju JH; Park SH
Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
[TBL] [Abstract][Full Text] [Related]
4. Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.
Soliman E; Labib W; el-Tantawi G; Hamimy A; Alhadidy A; Aldawoudy A
Rheumatol Int; 2012 Jun; 32(6):1711-20. PubMed ID: 21431945
[TBL] [Abstract][Full Text] [Related]
5. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
Pedersen SJ; Sørensen IJ; Lambert RG; Hermann KG; Garnero P; Johansen JS; Madsen OR; Hansen A; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen KH; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Østergaard M
Arthritis Rheum; 2011 Dec; 63(12):3789-800. PubMed ID: 22127697
[TBL] [Abstract][Full Text] [Related]
6. Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis.
Park MC; Chung SJ; Park YB; Lee SK
Yonsei Med J; 2008 Apr; 49(2):288-94. PubMed ID: 18452267
[TBL] [Abstract][Full Text] [Related]
7. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis.
Maksymowych WP; Rahman P; Shojania K; Olszynski WP; Thomson GT; Ballal S; Wong RL; Inman RD;
J Rheumatol; 2008 Oct; 35(10):2030-7. PubMed ID: 18785308
[TBL] [Abstract][Full Text] [Related]
9. Bone turnover biomarkers, disease activity, and MRI changes of sacroiliac joints in patients with spondyloarthritis.
Iaremenko O; Shynkaruk I; Fedkov D; Iaremenko K; Petelytska L
Rheumatol Int; 2020 Dec; 40(12):2057-2063. PubMed ID: 32979065
[TBL] [Abstract][Full Text] [Related]
10. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
[TBL] [Abstract][Full Text] [Related]
11. The occurrence of sacroiliitis in HLA-B*35-positive patients with undifferentiated spondyloarthritis. A cross sectional MRI study.
Šošo D; Aljinović J; Marinović I; Kojundžić SL; Jeličić EČ; Krstulović DM
Clin Rheumatol; 2020 Aug; 39(8):2299-2306. PubMed ID: 32107663
[TBL] [Abstract][Full Text] [Related]
12. Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters.
Konca S; Keskin D; Cılız D; Bodur H; Sakman B
Rheumatol Int; 2012 Dec; 32(12):3765-70. PubMed ID: 22159818
[TBL] [Abstract][Full Text] [Related]
13. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.
Arends S; Spoorenberg A; Bruyn GA; Houtman PM; Leijsma MK; Kallenberg CG; Brouwer E; van der Veer E
Osteoporos Int; 2011 May; 22(5):1431-9. PubMed ID: 20603707
[TBL] [Abstract][Full Text] [Related]
14. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
[TBL] [Abstract][Full Text] [Related]
15. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.
Maksymowych WP; Landewé R; Conner-Spady B; Dougados M; Mielants H; van der Tempel H; Poole AR; Wang N; van der Heijde D
Arthritis Rheum; 2007 Jun; 56(6):1846-53. PubMed ID: 17530713
[TBL] [Abstract][Full Text] [Related]
16. Radiomic Quantification for MRI Assessment of Sacroiliac Joints of Patients with Spondyloarthritis.
Tenório APM; Ferreira-Junior JR; Dalto VF; Faleiros MC; Assad RL; Louzada-Junior P; Nogueira-Barbosa MH; Rangayyan RM; de Azevedo-Marques PM
J Digit Imaging; 2022 Feb; 35(1):29-38. PubMed ID: 34997373
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers, imaging and disease activity indices in patients with early axial spondyloarthritis: the Italian arm of the SpondyloArthritis-Caught-Early (SPACE) Study.
Lorenzin M; Ortolan A; Vio S; Favero M; Oliviero F; Zaninotto M; Cosma C; Lacognata C; Punzi L; Ramonda R
Reumatismo; 2017 Aug; 69(2):65-74. PubMed ID: 28776360
[TBL] [Abstract][Full Text] [Related]
18. Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study.
Inman RD; Baraliakos X; Hermann KA; Braun J; Deodhar A; van der Heijde D; Xu S; Hsu B
Arthritis Res Ther; 2016 Dec; 18(1):304. PubMed ID: 28031053
[TBL] [Abstract][Full Text] [Related]
19. Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.
Navarro-Compán V; Ramiro S; Landewé R; Dougados M; Miceli-Richard C; Richette P; van der Heijde D
Ann Rheum Dis; 2016 May; 75(5):874-8. PubMed ID: 26403689
[TBL] [Abstract][Full Text] [Related]
20. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
